Digital Transformation In Cell Therapy

By Cytiva

To speed discovery and development and to create production process efficiencies, biopharmaceutical innovators are adopting machine learning, bioinformatics, and automation.

On a recent episode of The Business of Biotech, Dr. Mari Mitrani, co-founder and chief science officer of Organicell, and Dr. Michael Bellio, laboratory director, discussed how the clinical-stage regenerative medicine company has prioritized machine learning since its inception. Discover what they and other biopharmas are aiming to do with machine learning in the future.